Bypassing the need for pre-sensitization of cancer cells for anticancer TRAIL therapy with secretion of novel cell penetrable form of Smac from hA-MSCs as cellular delivery vehicle
Crossref DOI link: https://doi.org/10.1007/s13277-015-3058-2
Published Online: 2015-01-15
Published Print: 2015-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Khorashadizadeh, Mohsen
Soleimani, Masoud
Khanahmad, Hossein
Fallah, Ali
Naderi, Mahmood
Khorramizadeh, Mohammadreza
Text and Data Mining valid from 2015-01-15